News in Brief
Pharmacology - Nov 24
Novartis highlights confidence in growing sales with margin expansion, fueled by in-market brands and a rich pipeline, at Annual Meet the Management investor event
Novartis highlights confidence in growing sales with margin expansion, fueled by in-market brands and a rich pipeline, at Annual Meet the Management investor event
Campus - Nov 23
Culinary tourism, USI Master thesis leads to a report by the European Travel Commission
Culinary tourism, USI Master thesis leads to a report by the European Travel Commission
wire - news in brief
Category
Results 151 - 200 of 417.
In the consumer and services society people are increasingly exposed to financial products of all kinds, such as credit cards, car leasing, mortgage loans, investment funds for our savings, etc.
Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (I T) formulation in older patients with SMA to further support registration Basel, Septembe
Novartis Gene Therapies to initiate new pivotal confirmatory study to evaluate use of AVXS-101 intrathecal (I T) formulation in older patients with SMA to further support registration Basel, Septembe
Most people infected with SARS-CoV-2 develop symptoms
While some people who contract SARS-CoV-2 infections never experience any symptoms, there remains disagreement about what proportion of total infections these cases comprise.
While some people who contract SARS-CoV-2 infections never experience any symptoms, there remains disagreement about what proportion of total infections these cases comprise.
Loading of replicative helicases onto DNA is a key event during the initiation of chromosomal DNA replication.
Novartis Kisqali receives the highest rating of any CDK4/6 inhibitor on the ESMO Magnitude of Clinical Benefit Scale
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre
Kisqali is the only CDK4/6 inhibitor, in combination with endocrine therapy, to achieve a perfect 5 out of 5 score - confirming substantial benefit for premenopausal women with HR+/HER2- advanced bre
Patches to detect when a viral disease is about to get worse
Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin(TM) sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.
Xsensio, an EPFL spin-off, has just been awarded CHF 1.8 million in EU funding to adapt its Lab-on-Skin(TM) sensing patches so that they can detect when a viral illness like the flu or COVID-19 is about to get worse.
To cut food waste, we may need to pay more for what we eat
How can we reduce food waste? Although the Swiss population are aware of the problem, they misjudge where most food waste is generated, ETH political scientists conclude.
How can we reduce food waste? Although the Swiss population are aware of the problem, they misjudge where most food waste is generated, ETH political scientists conclude.
Speeding out of lockdown
Swissloop, the team of students developing hyperloop pods, took advantage of the break imposed by the coronavirus to improve the technology even further. Yesterday they unveiled their "research pod". At its core lies a technologically refined linear motor that will propel future prototypes at even faster speeds.
Swissloop, the team of students developing hyperloop pods, took advantage of the break imposed by the coronavirus to improve the technology even further. Yesterday they unveiled their "research pod". At its core lies a technologically refined linear motor that will propel future prototypes at even faster speeds.
HIV continues to be a major global health issue, having claimed almost 33 million lives.
Novartis Tafinlar + Mekinist demonstrates long-term, relapse-free survival benefit for high-risk, stage III melanoma patients in study published in NEJM
COMBI-AD is first trial to demonstrate 5-year relapse-free survival with targeted therapy as adjuvant treatment in high-risk patients with stage III BRAF-mutated melanoma 1 Adjuvant treatment with
COMBI-AD is first trial to demonstrate 5-year relapse-free survival with targeted therapy as adjuvant treatment in high-risk patients with stage III BRAF-mutated melanoma 1 Adjuvant treatment with
Catalyst Fund selects six projects in its 2020 funding round
The Catalyst Fund - supported by the Bertarelli Foundation - has selected six research projects to fund this year. Led by professors from EPFL and other Swiss Universities, these projects all aim to develop new treatment options for neurological disorders. Created by the Bertarelli Foundation in 2017, the Catalyst Fund aims to invest in translational projects targeting innovative approaches for diseases affecting the brain, spinal cord, peripheral nervous system and sensory organs.
The Catalyst Fund - supported by the Bertarelli Foundation - has selected six research projects to fund this year. Led by professors from EPFL and other Swiss Universities, these projects all aim to develop new treatment options for neurological disorders. Created by the Bertarelli Foundation in 2017, the Catalyst Fund aims to invest in translational projects targeting innovative approaches for diseases affecting the brain, spinal cord, peripheral nervous system and sensory organs.
Living at home in old age: This is what most older adults want. As a result, there is a high demand for senior apartments and tailor-made services for the care of older adults in need of assistance in their own households.
One application in which Brandao and the IT Services team have opted for AI is a key piece of research infrastructure known as the Leonhard cluster, which is specially designed for big data analytics and machine learning. "It offers features unmatched by any other cluster in the world and is very popular in biomedical research and other areas," says Brandao.
Protecting citizens in the face of disaster often requires far-reaching decisions to be made. Any assistance is welcome - including from AI.
Artificial intelligence is having a growing impact on our daily lives and is also revolutionising research.
A bioethicist and a neuroinformatics scientist discuss how machines are becoming more intelligent and why the advances in technology are leading to new ethical challenges.
The Inga hope a university will keep their indigenous heritage alive, safeguard the natural habitat of the Colombian rainforest and give the younger generation a future.
European Medicines Agency (EMA) approves safety label update for Novartis Beovu
Novartis worked with the EMA to update the Beovu (brolucizumab) label to guide physicians in their treatment of wet AMD The update includes the additional characterization of retinal vasculitis a
Novartis worked with the EMA to update the Beovu (brolucizumab) label to guide physicians in their treatment of wet AMD The update includes the additional characterization of retinal vasculitis a
Putting the users centre stage
Even if we succeed in combatting the COVID crisis, the challenges for the health system will not simply disappear. Digital technologies can be developed to help meet ongoing challenges; Nicole Wenderoth explains what should be borne in mind here. Across the globe, the COVID-19 pandemic has pushed healthcare systems to their limits, at least for the moment.
Even if we succeed in combatting the COVID crisis, the challenges for the health system will not simply disappear. Digital technologies can be developed to help meet ongoing challenges; Nicole Wenderoth explains what should be borne in mind here. Across the globe, the COVID-19 pandemic has pushed healthcare systems to their limits, at least for the moment.
Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis
New post hoc data from Phase III ASCLEPIOS trials showed newly diagnosed, treatment-naïve patients experienced reductions in annualized relapse rates, MRI lesion activity and reductions in time to di
New post hoc data from Phase III ASCLEPIOS trials showed newly diagnosed, treatment-naïve patients experienced reductions in annualized relapse rates, MRI lesion activity and reductions in time to di
Coronavirus: No quarantine for persons entering from border regions
At its meeting on 11 September, the Federal Council decided on the quarantine rules for persons entering Switzerland from neighbouring countries: only those regions of neighbouring countries where th
At its meeting on 11 September, the Federal Council decided on the quarantine rules for persons entering Switzerland from neighbouring countries: only those regions of neighbouring countries where th
On September 14, an expedition within the framework of the international project Ice Memory is setting out to carry out ice core drilling on the glacier of the mountain massif Grand Combin in the Swiss canton of Valais.
News in Brief
Pharmacology - Nov 24
Novartis highlights confidence in growing sales with margin expansion, fueled by in-market brands and a rich pipeline, at Annual Meet the Management investor event
Novartis highlights confidence in growing sales with margin expansion, fueled by in-market brands and a rich pipeline, at Annual Meet the Management investor event
Campus - Nov 23
Culinary tourism, USI Master thesis leads to a report by the European Travel Commission
Culinary tourism, USI Master thesis leads to a report by the European Travel Commission